Anavex Life Sciences Corp (AVXL)

[growingpain]

It is likely that they missed the original endpoints of the PDD trial and the AVATAR trial. However, both of the trials were modified and they are now considered successful. The PDD trial became a proof-of-concept trial with objectives instead of endpoints and under this label the results are very good. The AVATAR trial had new endpoints and became P3 a few weeks before the readout. The new endpoints were met but the original ones were never reported.